CAS 942655-44-9
:Formule :C18H17N3O3
InChI :InChI=1S/C18H17N3O3/c1-23-15-9-8-13(10-16(15)24-2)18(22)19-17-11-14(20-21-17)12-6-4-3-5-7-12/h3-11H,1-2H3,(H2,19,20,21,22)
Code InChI :QAZJUVDICQNITG-UHFFFAOYSA-N
SMILES :COC1=C(C=C(C=C1)C(=O)NC2=NNC(=C2)C3=CC=CC=C3)OC
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits trouvés.
JK-P3
CAS :Formule :C18H17N3O3Degré de pureté :>98.0%(HPLC)(T)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :323.353,4-dimethoxy-N-(5-phenyl-1H-pyrazol-3-yl)benzamide
CAS :Formule :C18H17N3O3Degré de pureté :98.0%Couleur et forme :SolidMasse moléculaire :323.3459JK-P3
CAS :JK-P3: a pyrazole inhibitor of VEGFR-2 (IC50: 7.8 μM), stalls FGFR 1/3 in vitro, halts HUVEC wound healing/tube formation, not cell growth.Formule :C18H17N3O3Degré de pureté :99.57%Couleur et forme :SolidMasse moléculaire :323.353,4-Dimethoxy-N-(5-phenyl-1H-pyrazol-3-yl)benzamide
CAS :Degré de pureté :≥98%Masse moléculaire :323.352JK-P3
CAS :JK-P3 is a tyrosine kinase inhibitor that blocks the enzymatic activity of tyrosine kinases. It has been shown to inhibit the growth of tumor cells by targeting receptor tyrosine kinases, factor receptor and other molecules that regulate cell growth. This drug has also been shown to be effective in clinical trials for the treatment of cancer.
Formule :C18H17N3O3Degré de pureté :Min. 95%Masse moléculaire :323.35 g/mol
